Christopher Brooke - Aug 11, 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Operating Officer
Signature
/s/ Mark K. Oki as attorney-in-fact for Christopher Brooke
Stock symbol
AYTU
Transactions as of
Aug 11, 2023
Transactions value $
$0
Form type
4
Date filed
8/15/2023, 08:30 PM
Previous filing
Nov 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYTU Employee Stock Option (Right to Buy) Award $0 +7K $0.00 7K Aug 11, 2023 Common Shares 7K $1.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/3 vest on August 11, 2024, with the remaining options vesting in 24 equal monthly installments, beginning September 11, 2024.